Bavarian Nordic seeks to expand monkeypox vaccine capacity

Bavarian Nordic vows to boost monkeypox vaccine supply to combat shortfall Bavarian Nordic, the maker of the only approved monkeypox vaccine, said on Wednesday it was exploring the viability of using technically expired doses to help bridge a growing gap between demand and supply due to the current outbreak. Natalie Grover,Stine Jacobsen Reuters

COPENHAGEN/LONDON, Aug 24 (Reuters) - Bavarian Nordic, the maker of the only approved monkeypox vaccine, said on Wednesday it was exploring the viability of using technically expired doses to help bridge a growing gap between demand and supply due to the current outbreak.

...